Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia
- 31 August 2013
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 34 (26), 6229-6238
- https://doi.org/10.1016/j.biomaterials.2013.04.061
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL065477)
- Ministry of Education, Science and Technology (2012K001394)
This publication has 21 references indexed in Scilit:
- Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardiumBiomaterials, 2011
- Ischemic heart diseases: Current treatments and futureJournal of Controlled Release, 2009
- Hypoxia-specific gene expression for ischemic disease gene therapyAdvanced Drug Delivery Reviews, 2009
- Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarctGene Therapy, 2008
- Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensorBlood, 2007
- Transcriptional and post-translational regulatory system for hypoxia specific gene expression using the erythropoietin enhancer and the oxygen-dependent degradation domainJournal of Controlled Release, 2007
- HIF-1α induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemiaJournal of Molecular and Cellular Cardiology, 2007
- Pathophysiology of heart failure following myocardial infarctionHeart, 2005
- Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular EndotheliumOnline Journal of Public Health Informatics, 2000
- VEGF Prevents Apoptosis of Human Microvascular Endothelial Cells via Opposing Effects on MAPK/ERK and SAPK/JNK SignalingExperimental Cell Research, 1999